Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis, the Wall Street Journal reported on Friday.
(Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva)
Bausch + Lomb to buy dry-eye drug from Novartis for $1.75 billion - WSJ
2023-06-30 19:19
Bausch + Lomb Corp will pay $1.75 billion to acquire a dry-eye drug from Swiss pharmaceutical giant Novartis,
You Might Like...
Biden bets on 'Bidenomics' for 2024 victory
French Apple workers call strike on iPhone 15 debut
Tourists find the Las Vegas Strip remade for its turn hosting Formula One
Asian markets turn lower on fresh rate hike worries
Bank of Korea tweaks lending facility to boost liquidity
Indonesia Aug trade surplus at $3.12 billion, bigger than expected
HiTHIUM and TÜV Rheinland Enter Into Strategic Partnership to Promote Green and Low-carbon Energy Transition
Guy Hands’s Former Care Home Business to Pay Dividend